Allurion Technologies (ALURW) Total Current Liabilities (2022 - 2026)
Allurion Technologies (ALURW) reported Total Current Liabilities of $37.3 million for Q1 2026, up 134.37% on a YoY basis from $15.9 million in Q1 2025, and down 3.09% quarter-over-quarter from $38.4 million in Q4 2025.
Allurion Technologies (ALURW) Total Current Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Total Current Liabilities for 5 years, with the latest figure at $37.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 134.37% year-over-year to $37.3 million; the trailing twelve-month figure through Mar 2026 stood at $37.3 million (up 134.37% YoY), and the FY2025 full-year result was $38.4 million, up 103.81% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $37.3 million, down from $38.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $89.9 million in Q2 2023, with the low at $11.6 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $43.2 million across 5 years, with a median of $37.3 million in 2026.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slumped 77.94% — and 2026, when it soared 134.37%.
- Allurion Technologies' Total Current Liabilities stood at $75.9 million in 2022, then dropped by 13.76% to $65.4 million in 2023, then tumbled by 71.17% to $18.9 million in 2024, then surged by 103.81% to $38.4 million in 2025, then dropped by 3.09% to $37.3 million in 2026.
- The last three Total Current Liabilities figures came in at $37.3 million (Q1 2026), $38.4 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 37.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.26 Mn |
| Dec 31, 2025 | 38.45 Mn |
| Sep 30, 2025 | 11.62 Mn |
| Jun 30, 2025 | 11.62 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 18.86 Mn |
| Sep 30, 2024 | 19.24 Mn |
| Jun 30, 2024 | 23.56 Mn |
| Mar 31, 2024 | 66.22 Mn |
| Dec 31, 2023 | 65.43 Mn |
| Sep 30, 2023 | 87.23 Mn |
| Jun 30, 2023 | 89.89 Mn |
| Dec 31, 2022 | 75.87 Mn |